Overview of recall records associated with Phadia US Inc., including dates, categories and classifications where available.
Classification mix: Class II: 5.
Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).
The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met.
The stability specifications of ImmunoCAP Allergen c6, Amoxicilloyl were not met.
This page summarizes recall records in which the official source identifies Phadia US Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.
